MedCloud Minute
The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].
New research, published in JAMA Ophthalmology by the University of Colorado, reports that artificial intelligence analysis of eye photographs may help detect serious heart and lung conditions in premature infants. The approach uses machine learning to analyze retinal images typically captured during routine screening for retinopathy of prematurity, an eye disorder that can affect infants born early. By examining patterns in the blood vessels of the eye, researchers found the system may be able to identify signs associated with cardiopulmonary conditions affecting the infant. AI analysis of retinal imagery can help clinicians with early detection and can reduce the need for more invasive testing.
More
Posted by MedCloudInsider Editors on 03/09/20260 comments
Hoth Therapeutics, a clinical-stage biopharmaceutical company, announced that it will be using the OpenAI API to support research and development for its HT-KIT oncology program, a drug candidate being studied for potential cancer treatments. The technology is being used to analyze scientific literature and biomedical data related to KIT mutations and other cancer-related pathways. By applying AI tools to research workflows, Hoth aims to identify insights that could help guide the development of the experimental therapy. The OpenAI API has been integrated into the HT-KIT development workflow for preclinical data analysis, molecular modeling and preparing regulatory documents.
More
Posted by MedCloudInsider Editors on 03/09/20260 comments
Pivot Point Consulting, an IT consulting leader in the healthcare sector, has joined the Microsoft Rural Health Resiliency Program, an initiative designed to support rural hospitals and healthcare organizations in strengthening cybersecurity and advancing digital transformation. The collaboration focuses on helping underserved providers adopt secure cloud technologies and modern IT practices. The collaboration will implement Dragon Copilot readiness assessments, provide national webinars and demo, ensure workflow design governance is adhered to and provide education at major rural and digital health conferences. Rural hospitals can request a no-cost Dragon Copilot readiness assessment from Pivot Point Consulting.
More
Posted by MedCloudInsider Editors on 03/05/20260 comments
Quest Diagnostics, a leader in diagnostic information services, has introduced an AI-powered companion, called Quest AI Companion, within the MyQuest platform, designed to help patients better understand and act on their lab test results. The tool provides personalized explanations, contextual health information and suggested next steps based on individual diagnostic data, with the goal of improving patient engagement and clarity. Users can prompt the AI Companion to assist with composing questions to ask healthcare providers, empowering patients to have informed conversations with clinicians.
More
Posted by MedCloudInsider Editors on 03/03/20260 comments
Aingens, a life sciences software company, has released the findings of a clinical AI reliability test for its platform, MACg (Medical Affairs Content generator), designed to evaluate the performance and safety of AI systems deployed in healthcare environments. The initial results showed zero hallucinations during testing, with 100% accuracy for numerical data, positioning the framework as a benchmark for validating AI accuracy in clinical use cases. The aim of releasing the results is to establish clearer benchmarks and governance standards for AI evaluation and deployment in evidence-critical workflows.
More
Posted by MedCloudInsider Editors on 03/02/20260 comments
XtalPi, a leading AI and robotics-driven drug discovery platform, announced that its platform has supported a clinical milestone for ReviR Therapeutic's investigational therapy RTX-117, a candidate targeting a rare neurological disorder. The platform helped accelerate key stages of research and development leading up to the clinical advancement. The discovery amplifies how AI-driven precision drug discovery can overcome traditional economic barriers in rare disease R&D. The success of RTX-117 validates the scalability and clinical impact of AI and robotics in expanding treatment options for minority patient groups.
More
Posted by MedCloudInsider Editors on 03/02/20260 comments
b.well Connected Health, specialists in digital experiences, has introduced bailey, a ready-to-deploy, white-label AI health assistant designed for healthcare organizations, payers and digital health platforms. bailey can be customized and embedded into existing patient engagement applications, allowing organizations to offer AI-driven guidance under their own brand. Built on the same core infrastructure used by OpenAI and Samsung to power health agents, bailey is built on the b.well Health AI SDK connects data through a 13-step data refinery for a longitudinal health record. bailey offers complete health data integration, agentic AI architecture developed at scale, action-oriented AI, healthcare-grade security, consumer-first privacy and rapid deployment that is white-label ready.
More
Posted by MedCloudInsider Editors on 02/24/20260 comments
Mammotome, a breast cancer treatment company, has launched the Mammotome Prime MR system, described as the first in-room MR vacuum-assisted breast biopsy system, designed to allow clinicians to perform MRI-guided biopsies within the MRI suite. The system enables tissue sampling without requiring patients to be moved to a separate procedure area, aiming to streamline workflow and reduce procedure time. The Mammotome Prime MR system enables a stronger vacuum with larger tissue samples and an 8-gauge needle.
More
Posted by MedCloudInsider Editors on 02/24/20260 comments
Researchers at the University of Missouri are developing methods to make AI-driven scientific predictions more trustworthy by improving model transparency and reliability. The team is focused on strengthening confidence in machine learning systems used to analyze complex scientific data, particularly in areas where inaccurate predictions could have significant downstream consequences. The database, called PSBench includes 1.4 million annotated protein structure models that give scientists reliable information needed to build AI systems to assess the quality of protein structure models. Previous tools lack the information required to accurately predict every type of protein, but PSBench provides a solution to this marking a significant step in applying protein models to develop treatments.
More
Posted by MedCloudInsider Editors on 02/20/20260 comments
Metabolon, a global leader in metabolomics, announced that its metabolomics platform enabled what the company describes as the largest metabolomic analysis to date in CAR-T cell therapy, generating new insights into severe neurotoxicity associated with the treatment. The study analyzed metabolic profiles from patients undergoing CAR-T therapy and identified distinct metabolite patterns correlated with immune effector cell-associated neurotoxicity syndrome (ICANS), a potentially life-threatening complication. Researchers were able to identify clear, reproducible metabolic signatures that classified patients who developed high-grade NEs using metabolomics to reveal mechanisms that are invisible to genomic, proteomic and cellular assays.
More
Posted by MedCloudInsider Editors on 02/18/20260 comments
Unchained Labs, a life sciences research company, has launched Stuntman, a new AI-driven automation platform designed to help life sciences teams accelerate experimental workflows and reduce reliance on manual laboratory processes. Stuntman combines artificial intelligence, robotics and software orchestration to automate complex, multi-step experiments, allowing scientists to focus more on analysis and discovery rather than routine execution. The integration allows scientists to describe what they aim to do in natural language and have these prompts turn into workflows, help plan experiments, interpret results and guide automation.
More
Posted by MedCloudInsider Editors on 02/09/20260 comments
MetaVia, a clinical-stage biotechnology company specializing in cardiometabolic diseases, has reported positive results from AI-based modeling conducted as part of its ongoing collaboration with Syntekabio, confirming key therapeutic targets for vanoglipel. The modeling work validated the biological mechanisms underlying the drug candidate, strengthening confidence in its development strategy and supporting continued clinical and preclinical efforts. MetaVia aims to continue leveraging Syntekabio AI to optimize the therapeutic profile of vanoglipel.
More
Posted by MedCloudInsider Editors on 02/09/20260 comments